Preclinical biotech developing immunotherapies for blood cancers and solid tumors.
Industry: Health Care
First Day Return: -4.2%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/11/2020 |
Offer Price | $12.00 |
Price Range $12.00 - $14.00 | |
Offer Shares (mm) | 1.3 |
Deal Size ($mm) | $15 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/15/2020 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $15 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Houston, TX, United States |
Founded | 2006 |
Employees at IPO | 11 |
Website www.kiromic.com |